AVROBIO, Inc. (AVRO) stock gained in the pre-market; here is why?
Shariq Khan
February 9, 2022
AVROBIO, Inc. (AVRO) gained significantly in the pre-market after the company announced Phase ½ clinical trial results for cystinosis. AVRO values at $1.80, gaining more